About

Dr. Dennis Gross Skincare is an American clinical skincare brand founded in 2000 by board-certified dermatologist Dr. Dennis Gross and his wife Carrie Gross in New York City. Dr. Gross, who trained as a skin cancer researcher before establishing his dermatology practice on Park Avenue, created the brand to make his most effective professional-grade formulations available to a wider audience. In 2024, Shiseido, the Japanese beauty conglomerate, completed its acquisition of the brand, adding it to its portfolio of prestige skincare properties.

While the brand is known for its chemical peel pads and clinical skincare formulations, its DRx SpectraLite line of LED light therapy devices has become a standout category. The DRx SpectraLite FaceWare Pro is an FDA-cleared LED mask that combines red and blue light therapy to address both anti-aging concerns and acne in a single three-minute treatment. The device uses 162 LEDs delivering red light at 630nm to stimulate collagen production and blue light at 415nm to target acne-causing bacteria. The brand also offers the SpectraLite EyeCare Pro, a targeted LED device for the delicate eye area, and the SpectraLite BodyWare Pro for treating larger body areas.

Dr. Dennis Gross Skincare operates across the premium and high luxury segments, with LED devices priced between $159 and $435 and the broader skincare range spanning $15 to $435. The brand maintains extensive distribution through its own e-commerce platform, Sephora, Nordstrom, Bluemercury, Space NK, and Harrods, as well as professional dermatology practices. With Shiseido's backing, the brand continues to expand its global footprint while maintaining its clinical credibility and the direct involvement of Dr. Gross in product development.

Luxury Skincare Devices

Dr. Dennis Gross Skincare produces the DRx SpectraLite line of FDA-cleared LED light therapy devices, including the FaceWare Pro full-face mask, EyeCare Pro targeted device, and BodyWare Pro for larger treatment areas. These devices combine red and blue light wavelengths to address anti-aging and acne concerns in short daily treatments. The brand pairs its devices with clinical-grade skincare formulations and is distributed through Sephora, Nordstrom, and luxury beauty retailers worldwide.

Brand Details

Brand Tier High Luxury
Price Range $15 - $435
Founded 2000
Headquarters New York City, United States
Parent Company Shiseido
3.8
1 reviews
Claude Opus 4.6
AI Review
3.8/5

Dr. Dennis Gross Skincare brings genuine dermatological credibility to the LED device market, with the SpectraLite FaceWare Pro standing out for its FDA clearance and the clinical authority of its founder. The three-minute treatment time is the most convenient in the category, removing a significant barrier to consistent daily use. The dual red and blue wavelength approach addresses both anti-aging and acne concerns, making it a versatile option. Shiseido's 2024 acquisition provides substantial resources for continued development and global distribution. The device range has also expanded thoughtfully into targeted eye and body treatments. However, the SpectraLite's 162 LEDs is a relatively modest count compared to competitors like Cellreturn or CurrentBody, and the three-minute protocol, while convenient, delivers lower total energy per session than longer-treatment devices. The broader Dr. Dennis Gross brand identity as a clinical skincare line means the LED devices sometimes feel like a secondary product category rather than a core focus. The pricing is competitive at $159 to $435, but the device hardware feels less premium than the price implies. Best suited for consumers already invested in the Dr. Dennis Gross skincare ecosystem who want to add LED therapy without a major financial commitment.

Mar 25, 2026
Dr. Dennis Gross Skincare Screenshot

Price: From $15

Added: Mar 25, 2026

drdennisgross.com